Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for type 2 diabetes management and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities
Seek medical attention for significant overdoses
Both hypertrophic scars and keloids form exaggerated ECM structures, but different collagen organization, composition and proliferation dynamics suggest different cross-linking and pro-fibrotic mechanisms
The SUSTAIN trials encompassed global international studies (SUSTAIN 1 through 10), with three additional trials dedicated to China and Japan [7]
These medications work through different mechanisms and are metabolized via separate pathways, which reduces the likelihood of direct drug-drug interactions
Retatrutide , an investigational drug from Eli Lilly and Company , is a prime example of this innovation